The Nursing Management of Intrapleural Chest Tubes enduring module is a recording from the live Regularly Scheduled Series held on July 9, 2025. If you received credit for attending this session during the live meeting, please refrain from claiming credit for this module.

Faculty

Needs Statement

UK HealthCare recognizes the importance of safe, evidence-based care for patients with an intrapleural chest tube. This session addresses the indications for an intrapleural chest tube and the nurse’s role in managing the care and comfort needs of the patient with an intrapleural chest tube. 

Target Audience

UK HealthCare Registered Nurses and Licensed Practical Nurses

Objectives

After this session, participants will be able to:

• List the indications for insertion of an interpleural chest tube.
• Describe the nursing management of a patient with an intrapleural chest tube.
• Discuss nursing interventions to provide safe care for a patient with an intrapleural chest tube

Accreditation

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.50 nursing contact hours.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

In collaboration with UK HealthCare.